TRMT6 and neoplasm: Moreover, the differences in enrichment scores of T cells gamma delta and Mast cells activated between the high and low expression groups also suggested that TRMT6 contributes to poor prognosis in OC patients by promoting tumor immune escape, rather than through conventional pathways like facilitating lymph node metastasis.